School of Medicine
Showing 12,161-12,180 of 12,907 Results
-
Jennifer Williams
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Williams is a fellowship-trained pulmonologist specializing in pulmonary critical care medicine. She has board certification in pulmonary medicine, critical care medicine, and internal medicine.
She is a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine.
For each patient, Dr. Williams develops a comprehensive and compassionate care plan. Her goal is to help every individual achieve the best possible lung health and quality of life.
Patient reviews praise the quality of the care she delivers, her thoroughness, and her patient skills.
Dr. Williams has participated in clinical research studies. She has published articles on autoimmune disease involving interstitial lung disease, COPD, and life-threatening pulmonary complications associated with leukemia. She also co-authored an article on the development of guidelines for identifying and managing post-traumatic stress disorder symptoms associated with critical illness.
Her work has appeared in peer-reviewed journals including the American Journal of Respiratory and Critical Care Medicine, Internal Medicine, and elsewhere. She also has written chapters in books on critical care medicine and clinical decision-making.
Dr. Williams speaks English and both written and oral medical Spanish. In her free time, she enjoys soccer and distance running. -
Leanne Williams
Vincent V.C. Woo Professor, Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and, by courtesy, of Psychology
Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.
-
Nolan Williams
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator) and, by courtesy, of Radiology (Neuroimaging and Neurointervention)
BioNolan Williams, M.D. is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Rokeena Williams
eLearning Manager, School of Medicine - Post Grad Med Education (CME)
Current Role at StanfordeLearning Manager
-
Sarah R. Williams MD, MHPE, ACC
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsExploring ways to incorporate coaching into medical education.
Investigating ways to innovate medical education training across specialties.
Investigating applications of clinician-performed point-of-care ultrasound for emergency and critical care patients.
Improving safety of transitions of care between providers during sign-out. -
Sharon E. Williams PhD
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Williams work focuses primarily on cognitive and emotional recovery of children who have been medically compromised. With improved medical treatment and increased survival rates comes the need to better understand the challenges that patients face following a life threatening illness or injury. Dr. Williams utilizes neuropsychological assessments to understand the cognitive abilities of children who have been diagnosed with cancer, head injuries, genetic disorders and other medical conditions.
-
Julie Williamson, DO, FAAP
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor (By courtesy), Pediatrics - Critical CareBioDr. Williamson practices pediatric anesthesiology and critical care. She is committed to undergraduate and graduate medical education, and has served as an Educator-for-CARE at the Stanford School of Medicine and as a program director for Anesthesiology at Emory University. She is affiliated with several mentoring and advising programs, including the Stanford Anesthesiology Mentoring Program and the Women's Empowerment and Leadership Initiative for Pediatric Anesthesiologists.
-
Darrell Wilson
Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research interests cover a number of areas in Pediatric Endocrinology and Diabetes. I am PI of the Stanford Center for the NIH-funded Type-1 Diabetes TrialNet group. TrialNet conducts clinical trials directed at preventing or delaying the onset of Type 1 diabetes. I am an investigator in DirecNet, another NIH-funded study group, which is devoted to evaluating glucose sensors and the role of technology on the management of diabetes.
